ARK Genomic Revolution ETF vs Vanguard Tax Managed Fund FTSE Developed Markets ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.5, while Vanguard Tax Managed Fund FTSE Developed Markets ETF trades at $72.9. Which is the better fit depends on your goals.
| ARKG | VEA | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $44.55 | $72.89 |
52-Week Low | $24.02 | $58.19 |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 4022 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VEA →